Navigation Links
BMP Sunstone Receives Production License from the SFDA to Manufacture and Market Pediatric Multivitamin Granules in the PRC
Date:8/18/2008

tements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts, including but not limited to statements about the expected launch date of the SFDA-approved multivitamin formula, the market for pediatric vitamins within the next 5 years at a sustainable annual growth rate of 15%, the turnaround in capturing market share, our ability to be a market leader in the pediatric pharmaceutical market, the SFDA-approved multivitamin formula providing an additional revenue stream for BMP Sunstone, the ability of the Company to leverage the GoodBaby brand and marketing channels to extend the Company's product portfolio through internal development efforts and external product acquisitions, the possible approval of additional products by the SFDA in the future, being the market leader in women's and children's health and maximizing shareholder value. . These statements are subject to uncertainties and risks including, but not limited to, our ability to successfully launch the SFDA-approved multivitamin formula, competitors in the multivitamin market, our ability to take advantage of synergies between our various subsidiaries and other risks contained in reports filed by the Company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.

For more information, please contact:

BMP Sunstone Corporation

Fred M. Powell

Chief Financial Officer

Tel: +1-610-940-1675

Integrated Corporate Relations, Inc.

Ashley Ammon MacFarlane a
'/>"/>

SOURCE BMP Sunstone Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. BMP Sunstone Reports Second Quarter 2008 Financial Results
2. BMP Sunstone Corporation Appoints Zhiqiang Han to President and Chief Operating Officer
3. BMP Sunstone Receives Import Drug License (IDL) from SFDA
4. BMP Sunstone Receives SFDA Acceptance for Enablex(R) Clinical Trial
5. XTL Biopharmaceuticals Receives Notice of Non-Compliance with Nasdaq Marketplace Rule Due to Changes in Board Composition
6. CV Therapeutics Receives European Approval for the Brand Name Ranexa(R)
7. SGX - Lilly Merger Offer Receives Positive Opinions From Proxy Advisory Firms
8. Angiotech receives CE Mark approval of HemoStream(TM) Chronic Dialysis Catheter
9. Medicsight Receives Brazilian State Food and Drug Administration Approval for ColonCAD Software
10. ImQuest Receives $6.4 M Five Year Award from NIH to Develop Long-Lasting Combination Topical Microbicides To Prevent HIV Transmission
11. Kiwa Bio-Tech Receives Nationally Recognized Organic Products Certification
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... YORK , July 28, 2015 People ... by hearing aids achieved significant and sometimes profound improvements ... cochlear implant devices, according to a new multicenter study ... In the study, described online ahead of print in ... medical centers and private clinics in the ...
(Date:7/28/2015)... 2015 Research and ... of the "Analysis of the Global Flow ... Globally, flow cytometry remains a popular ... cancer, and stem cells. But the market is ... of demand from underdeveloped nations to quantitate CD4 ...
(Date:7/28/2015)... July 28, 2015 Deerfield Management Company, L.P. ... Fund, L.P., which will invest in groundbreaking advancements in ... diseases, cancer, and orphan diseases. The venture capital fund ... therapeutics are developed and improve the way healthcare is ... the largest healthcare-focused venture funds in the sector, will ...
(Date:7/28/2015)... 28, 2015  Moerae Matrix Inc. announced today ... trial with MMI-0100, a first-in-class inhibitor of MAPKAP ... pulmonary disorders characterized by inflammation and fibrosis.  The ... , is a double-blind, two-way cross-over design ... and tolerability of MMI-0100 when given via inhalation ...
Breaking Biology Technology:Hybrid Cochlear Implants For Common Form Of Hearing Loss May Benefit Millions 2Hybrid Cochlear Implants For Common Form Of Hearing Loss May Benefit Millions 3Analysis of the Global Flow Cytometry Market 2012-2018 with a 2014 Base Year and a 2015-2018 Forecast Period 2Deerfield Launches $550 Million Healthcare Venture-Capital Fund 2Deerfield Launches $550 Million Healthcare Venture-Capital Fund 3Moerae Initiates Lipopolysaccharide (LPS) Challenge Study of Inhaled MMI-0100 for Pulmonary Disease Following Encouraging Safety and Tolerability Observed in Single Ascending Dose Phase 1 Study 2
... 26 Mylan Inc. (NYSE: MYL ),today ... Vice President,Global Corporate Communication and Public Relations. Mr. ... communications and provide,communications and public relations counsel to ... various roles across the Company., Mr. Zylstra ...
... Inc.,(Nasdaq: NGSX ), a biopharmaceutical company focused ... it is scheduled to present,on Wednesday, November 28, ... New York City. Anthony DiTonno, President and Chief ... Financial Officer,will be available to respond to questions ...
... DECATUR, Ill., Nov. 26 Archer Daniels Midland,Company ... Camp, executive vice,president, has elected to retire by ... on a special assignment to advance the,Company,s business ... now transitions to the Company,s strategic planning group,under ...
Cached Biology Technology:Mylan Announces Appointment of Steven G. Zylstra as Vice President of Global Corporate Communication and Public Relations 2NeurogesX to Present at Lazard Capital Markets Healthcare Conference 2NeurogesX to Present at Lazard Capital Markets Healthcare Conference 3ADM Executive Vice President Bill Camp to Retire 2
(Date:7/8/2015)... 8, 2015  Trovagene, Inc. (NASDAQ: TROV ... announced the launch of a study that aims ... Monitoring℠ (PCM) technology for predicting response to treatment ... combination of the novel immunotherapy agents Yervoy® (ipilumumab), ... inhibitor. The 50-patient study will be led by ...
(Date:7/2/2015)... , June 25, 2015 ... announced the addition of the "Natural Language ... Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) ... their offering. The key vendors occupying ... HP, IBM Corporation, Microsoft Corporation, NetBase Solutions, SAS ...
(Date:6/29/2015)... , June 24, 2015 ... addition of the "Latin America Biomedical Sensors Market ... their offering. The Latin America Biomedical Sensors ... a CAGR of 2.04% over the period 2014-2020 ... are adaptable to the genetic formulation of each individual. ...
Breaking Biology News(10 mins):Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020 2Latin America Biomedical Sensors Market Report 2015-2020 2
... AMES, Iowa A national panel led ... effort to research and develop technologies that capture, ... ecosystems, economic development and national security. The ... recently met for the first time in Chicago. ...
... This press release is available in German . ... the heart muscle, for example myocardial infarction and cardiomyopathy, which ... Max Planck Institute for Heart and Lung Research in Bad ... a protein which fulfils a central task in this reversion ...
... seems that there is no such thing as all-occasion camouflage. ... But in the deeper ocean, where predators are equipped with ... go in darker colors. That,s according to a report ... a Cell Press publication. Sarah Zylinski and Snke Johnsen ...
Cached Biology News:Iowa State engineers establish national panel to advance a carbon negative economy 2Iowa State engineers establish national panel to advance a carbon negative economy 3Diseased hearts to heal themselves in future 2Diseased hearts to heal themselves in future 3For deep-sea cephalopods, 'switchable' camouflage saves the day 2
Human HVEM/TNFRSF14 Allophycocyanin MAb (Clone 94801)...
Mature rat whole blood (Sprague-Dawley, averaging 7-8 weeks of age, either sex) is collected at the time of slaughter and processed within 45 minutes. It is then filtered through gauze, pooled in an ...
... Freezing Point Osmometer for 10 L ... applications, including pediatric, neonatal, geriatric, general ... Automatic Calibration with 2 or 3 ... keypad and software for statistical analysis ...
X-gal,1g...
Biology Products: